{"id":7241,"date":"2025-04-14T17:56:56","date_gmt":"2025-04-14T15:56:56","guid":{"rendered":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/?p=7241"},"modified":"2025-04-14T17:56:57","modified_gmt":"2025-04-14T15:56:57","slug":"boletin-no-11","status":"publish","type":"post","link":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/boletin-no-11\/","title":{"rendered":"Bolet\u00edn n\u00ba 11"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"724\" height=\"1024\" src=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0001-724x1024.jpg\" alt=\"\" class=\"wp-image-7242\" style=\"width:960px;height:auto\" srcset=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0001-724x1024.jpg 724w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0001-212x300.jpg 212w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0001-768x1086.jpg 768w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0001-1086x1536.jpg 1086w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0001.jpg 1241w\" sizes=\"auto, (max-width: 724px) 100vw, 724px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"724\" height=\"1024\" src=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0002-724x1024.jpg\" alt=\"\" class=\"wp-image-7243\" style=\"width:960px;height:auto\" srcset=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0002-724x1024.jpg 724w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0002-212x300.jpg 212w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0002-768x1086.jpg 768w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0002-1086x1536.jpg 1086w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0002.jpg 1241w\" sizes=\"auto, (max-width: 724px) 100vw, 724px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"724\" height=\"1024\" src=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0003-724x1024.jpg\" alt=\"\" class=\"wp-image-7244\" style=\"width:960px;height:auto\" srcset=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0003-724x1024.jpg 724w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0003-212x300.jpg 212w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0003-768x1086.jpg 768w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0003-1086x1536.jpg 1086w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0003.jpg 1241w\" sizes=\"auto, (max-width: 724px) 100vw, 724px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"724\" height=\"1024\" src=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0004-724x1024.jpg\" alt=\"\" class=\"wp-image-7245\" style=\"width:960px;height:auto\" srcset=\"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0004-724x1024.jpg 724w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0004-212x300.jpg 212w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0004-768x1086.jpg 768w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0004-1086x1536.jpg 1086w, https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-content\/blogs.dir\/6\/files\/sites\/76\/2025\/04\/Boletin-no-11-MARZO-2025_page-0004.jpg 1241w\" sizes=\"auto, (max-width: 724px) 100vw, 724px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":59,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7241","post","type-post","status-publish","format-standard","hentry","category-blog","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"_links":{"self":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/7241","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/comments?post=7241"}],"version-history":[{"count":1,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/7241\/revisions"}],"predecessor-version":[{"id":7246,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/posts\/7241\/revisions\/7246"}],"wp:attachment":[{"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/media?parent=7241"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/categories?post=7241"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ccoo.app\/towa-pharmaceutical-europe\/wp-json\/wp\/v2\/tags?post=7241"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}